Magnetic resonance imaging for liver cirrhosis using functionalized contrast agent

Teruhiko Shigeoka, Masaharu Murata, Shohei Yamaguti, Takeshi Mori, Takuro Niidome, Yoshiki Katayama, Makoto Hashizume

Research output: Contribution to conferencePaper

Abstract

Advances in molecular imaging provide new insights into the pathophysiology of many diseases. In this research, we have development functional molecule for MRI contrast agent of the liver. The agent, LAC-DOTA, is expected accumulation into hepatocytes. The molecular imaging ability of LAC-DOTA was measured by measuring the liver imaging ability of a normal mouse and a liver cirrhosis mouse. The LAC-DOTA enhanced MRI imaging may be emerged as a promising modality for detection and diagnosis of liver cirrhosis.

Original languageEnglish
Number of pages1
Publication statusPublished - Oct 19 2006
Event55th SPSJ Annual Meeting - Nagoya, Japan
Duration: May 24 2006May 26 2006

Other

Other55th SPSJ Annual Meeting
CountryJapan
CityNagoya
Period5/24/065/26/06

    Fingerprint

All Science Journal Classification (ASJC) codes

  • Engineering(all)

Cite this

Shigeoka, T., Murata, M., Yamaguti, S., Mori, T., Niidome, T., Katayama, Y., & Hashizume, M. (2006). Magnetic resonance imaging for liver cirrhosis using functionalized contrast agent. Paper presented at 55th SPSJ Annual Meeting, Nagoya, Japan.